Cardiac Arrhythmias 1999: Vol.1. Proceedings of the 6th International Workshop on Cardiac Arrhythmias (Venice, 5–8 October 1999)

Front Matter....Pages I-XVIII
Front Matter....Pages 1-1
Sudden Ischemic Cardiac Death: The Clinical Approach....Pages 3-5
Molecular Pathology of Cardiac Diseases Liable to Cause Sudden Death....Pages 6-33
Front Matter....Pages 35-35
Are All Paroxysms of Atrial Fibrillation Focally Initiated?....Pages 37-43
How Common Is a Genetic Origin of Atrial Fibrillation?....Pages 44-49
Lone Atrial Fibrillation: What Is the Anatomical and the Electrophysiological Substrate?....Pages 50-57
Atrial Fibrillation in Apparently Idiopathic Cardiomyopathy: The Chicken or the Egg?....Pages 58-64
Cardioversion for Atrial Fibrillation Today: When and Why?....Pages 65-69
Acute Conversion of Recent-Onset Atrial Fibrillation and Flutter: Class IC or Class III Drugs?....Pages 70-79
Antiarrhythmic Drug Therapy Before Electrical Cardioversion of Atrial Fibrillation: Is It Really Useful?....Pages 80-84
Low-Energy Internal Defibrillation: How Many Patients Are Still in Sinus Rhythm After 1 Year?....Pages 85-90
How Useful Is Transoesophageal Echocardiography During Electrical Cardioversion for Predicting Long-Term Sinus Rhythm Maintenance?....Pages 91-98
Atrial Stunning Following Sinus Rhythm Restoration: Which Mechanism, Time Course and Implication for Anticoagulation?....Pages 99-104
Drug Prevention of Atrial Fibrillation: Are Novel Agents More Effective Than the Old Ones?....Pages 105-112
Atrial Pacing for Prevention of Atrial Fibrillation: Where and How to Stimulate?....Pages 113-119
Implantable Atrial Defibrillator: What are the Results of Initial Experience?....Pages 120-124
Implantable Atrial Defibrillator: What Are the Future Perspectives?....Pages 125-130
Implantable Atrial Defibrillator: Why not a Patient-Activated Drug Delivery System?....Pages 131-135
Ablation of Atrial Fibrillation: How Should Patients Be Selected?....Pages 136-142
An Anatomical Approach to Curing Atrial Fibrillation: Pulmonary Vein Isolation with Through-the-Balloon Ultrasound Ablation....Pages 143-148
Ablate and Pace Therapy or AV Junction Modification for Medically Refractory Atrial Fibrillation?....Pages 149-155
Front Matter....Pages 35-35
Atrial Fibrillation After Heart Surgery: How to Identify and Protect Predisposed Patients?....Pages 156-164
Front Matter....Pages 165-165
Clinically Documented but Not Inducible Atrioventricular Nodal Reentrant Tachycardia: To Ablate or Not To Ablate?....Pages 167-168
Permanent Junctional Reentry Tachycardia: When to Ablate, Where and With Which Results?....Pages 169-175
How to Predict and Avoid Complete AV Block Complicating Radiofrequency Ablation of AV Nodal Slow Pathway....Pages 176-184
Ablation of Antero-Septal and Intermediate Septal Accessory Pathways: How Safe Is It? How Can One Minimize the Risk of AV Block?....Pages 185-192
Acute Treatment of Atrial Flutter: Ibutilide, Transesophageal Pacing, or DC Shock?....Pages 193-197
Chronic Atrial Flutter: What Is the Risk of Thromboembolism?....Pages 198-201
Common and Uncommon Atrial Flutter: What Are the Long-Term Results and Complications of Radiofrequency Ablation?....Pages 202-211
Atrial Tachycardia Originating from Crista Terminalis....Pages 212-215
“Incisional” Reentrant Atrial Tachycardia: How to Prevent and Treat It?....Pages 216-225
Treatment of Tachyarrhythmias Using Cryothermal Energy....Pages 226-247
Front Matter....Pages 249-249
Idiopathic Ventricular Fibrillation: Is the Prognosis Always Bad?....Pages 251-254
The Syndrome of Right Bundle Branch Block, ST Segment Elevation in V1 to V3 and Sudden Death. Are Asymptomatic Patients at High Risk for Sudden Death?....Pages 255-261
Is Atrial Vulnerability Increased In Arrhythmogenic Right Ventricular Cardiomyopathy?....Pages 262-267
Is Right Ventricular Outflow Tract Tachycardia a Minor Form of Arrhythmogenic Right Ventricular Cardiomyopathy?....Pages 268-275
Electrophysiologic Mechanisms of Polymorphic Ventricular Tachycardia/Torsade de Pointes in the Presence of Normal or Long QT....Pages 276-284
Sudden Infant Death Syndrome and Long-QT Syndrome: What is Their Relationship?....Pages 285-290
Brugada and Long QT Syndrome Are Two Different Diseases: True or False?....Pages 291-298
Effect of β-Blocker Therapy on the Frequency and Type of Cardiac Events in Patients with the Hereditary Long QT Syndrome....Pages 299-305
Gene Therapy for Long QT Syndrome: Fact or Fiction?....Pages 306-310
Front Matter....Pages 249-249
An Overview of Secondary Prevention Implantable Cardioverter-Defibrillator Trials: AVID, CIDS and CASH....Pages 311-318
What Has Been the Impact on Clinical Practice of Recently Published Postevent ICD Trials?....Pages 319-325
Is the Implantable Defibrillator Cost-effective?....Pages 326-333
What Is the Best Algorithm to Discriminate Between Supraventricular and Ventricular Tachyarrhythmias?....Pages 334-340
Transthoracic Epicardial Mapping and Ablation of Post-Infarction Ventricular Tachycardia: The Right Solution to the Problem?....Pages 341-348
Front Matter....Pages 349-349
Risk Stratification for Serious Arrhythmic Events in Post-Infarction Patients....Pages 351-360
What Is the Clinical and Prognostic Significance of High-Resting Sinus Rate?....Pages 361-368
What is the Relationship Between Depression, the Autonomic Nervous System and the Risk of Death in Post-Myocardial Infarction Patients?....Pages 369-372
Does Baroreflex Sensitivity Add Something to Noninvasive Evaluation of Post-Infarction Patients?....Pages 373-378
Does Electrophysiologic Study Allow Further Risk Stratification in Survivors of Acute Myocardial Infarction?....Pages 379-385
The BEST + ICD Trial: Is ICD Also Effective in the Presence of Optimized β-Blocking Therapy?....Pages 386-397
SEDET Trial: Is Noninvasive Evaluation Sufficient to Identify Patients at High Risk of Arrhythmia?....Pages 398-402
DINAMIT: Does ICD Implantation Improve Life Expectancy in Survivors of Acute Myocardial Infarction?....Pages 403-406
What Are the Clinical Implications of MUSTT?....Pages 407-412
ALIVE Trial: How Is This Trial Design Different?....Pages 413-416
Front Matter....Pages 417-417
What is the Value of Clinical History in Establishing the Cause of Syncope?....Pages 419-422
Adenosine-Sensitive Syncope: Does it Really Exist?....Pages 423-429
Idiopathic Postural Orthostatic Tachycardia: A Variant of Neurocardiogenic Syncope?....Pages 430-436
Syncope of Unknown Origin After Electrophysiologic Study and Head-Up Tilt Test: How Useful is an Implantable Loop Recorder?....Pages 437-441
Nitrotest Versus Isotest for Vasovagal Syncope: Do They Explore Different Mechanisms?....Pages 442-448
Front Matter....Pages 417-417
Is the Type of Cardiovascular Response During Tilt Table Testing Useful for the Choice of the Treatment? The New VASIS Classification....Pages 449-462
Midodrine for Treatment of Vasovagal Syncope....Pages 463-468
Vasovagal Syncope: To Pace or not to Pace?....Pages 469-474
Patient-Activated Implantable Drug Delivery System for Treatment of Vasovagal Syncope: A Simple Solution?....Pages 475-482
Front Matter....Pages 483-483
Lead Extraction: How Easy and Safe Is It Today?....Pages 485-493
Pacemaker/ICD Patients: To Anticoagulate or Not To Anticoagulate?....Pages 494-500
How Risky Are Cellular Telephones for Patients Implanted with a Pacemaker or ICD?....Pages 501-508
What Are the Risks for Pacemaker/ICD Patients Undergoing Magnetic Resonance Imaging or Other Medical Procedures?....Pages 509-513
Pacemaker Treatment for Hypertrophic Obstructive Cardiomyopathy: Are Long-Term Results as Good as Short-Term Ones?....Pages 514-521
Theophylline for Treatment of Bradyarrhythmias: When Is it Indicated?....Pages 522-529
SSS Patients: Atrial or Dual-Chamber Pacing?....Pages 530-533
Mobitz I AV Block: Why and When to Pace?....Pages 534-536
Patients Implanted for AV Block: How Many Subsequently Develop Sinus Node Dysfunction?....Pages 537-540
Optimizing the AV Delay in DDD Pacemakers: How Useful Is it?....Pages 541-544
What Are the Long-Term Benefits of the Dual-Chamber Rate-Responsive System Driven by Contractility?....Pages 545-550
Haemodynamic Sensors: What is Their Role in Monitoring Heart Function?....Pages 551-559
What Is the Optimal Site for Right Ventricular Pacing: Outflow Tract or Apex?....Pages 560-564
Treatment of Severe Heart Failure: Is Left Ventricular Pacing Alone Enough or Do We Need Biventricular Pacing?....Pages 565-568
Multisite Biventricular Pacing to Treat Refractory Heart Failure: Why and How?....Pages 569-580
Biventricular Pacing: Is Acute Hemodynamic Evaluation Useful to Select Patients?....Pages 581-588
Back Matter....Pages 589-591